Doug Bunting

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
OBJECTIVE To test in a double blind, placebo-controlled study a purified fusion protein (PFP-2) vaccine against respiratory syncytial virus (RSV) in RSV-seropositive children with cystic fibrosis (CF). METHODS Seventeen CF children, mean age 4.5 years, received PFP-2 vaccine and 17 CF children, mean age 5.8 years, received a saline vaccine. At enrollment(More)
The determinants of the PD prescription for adequate dialysis are residual renal clearance, target clearance, patient size (gender, height, weight, and, in men only, age), and some information about peritoneal transport characteristics, usually obtained from a PET (anticipated D/P, anticipated Vuf). With this information, PD schedules providing adequate(More)
  • 1